ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,001.55
-1.38%
US Tech 100
16,740.00
-1.88%
Dow Jones
37,873.21
-1.53%
Brent Oil
86.685
-0.61%
Bitcoin
63,278.00
-1.56%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. UroGen Pharma Ltd (URGN) Quote

UroGen Pharma Ltd

UroGen Pharma Ltd (URGN)

NASDAQ
13.78
-0.43
( -3.03% )
Updated: 09:34:42
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
13.78
Bid
13.77
Ask
13.94
Volume
2,213
13.78 Day's Range 14.235
8.69 52 Week Range 24.13
Market Cap
470.202M
Previous Close
14.21
Open
14.05
Last Trade
100
@
13.78
Last Trade Time
09:32:17
Financial Volume
$ 30,992
VWAP
14.0046
Average Volume (3m)
371,989
Shares Outstanding
34,122,087
Dividend Yield
-
PE Ratio
-4.60
Earnings Per Share (EPS)
-3
Revenue
82.71M
Net Profit
-102.24M

About UroGen Pharma Ltd

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment opt... UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.urogen.com
Headquarters
Ra'anana, Center, Isr
Founded
1970
UroGen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker URGN. The last closing price for UroGen Pharma was $14.21. Over the last year, UroGen Pharma shares have traded in a share price range of $ 8.69 to $ 24.13.

UroGen Pharma currently has 34,122,087 shares outstanding. The market capitalization of UroGen Pharma is $470.20 million. UroGen Pharma has a price to earnings ratio (PE ratio) of -4.60.

URGN Latest News

More News

UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers

Subgroup analysis of the UGN-102 ATLAS Trial in patients with new versus recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) Three independent long-term...

April 17 2024
Business Wire

UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

UroGen plans to initiate a Phase 3 study to explore the safety and efficacy of UGN-103 in 2024 Anticipated advantages include a new 80 mg mitomycin dosage strength that may considerably shorten...

April 15 2024
Business Wire

UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced that it has filed a...

April 03 2024
Business Wire

UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102

Initiated submission of a rolling NDA to the FDA for UGN-102; 12-month duration of response data from ENVISION expected to support completion of NDA submission Announced next-generation novel...

March 14 2024
Business Wire

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of...

March 08 2024
Business Wire

UroGen Pharma to Report Fourth Quarter and Full-Year 2023 Financial Results on Thursday, March 14, 2024

Conference Call and Webcast Scheduled for Thursday, March 14, 2024, at 10:00 AM ET UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative...

March 04 2024
Business Wire

Form 8-K - Current report

March 04 2024
Edgar (US Regulatory)

Form 8-K - Current report

March 01 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.58-4.0389972144814.3614.8513.1725941914.16589094CS
4-1.14-7.6407506702414.9215.512.3730692214.29692968CS
12-1.98-12.563451776615.7619.8712.3737198916.24092981CS
262.2819.826086956511.519.8710.6331628215.14779866CS
522.2819.826086956511.524.138.6938164516.10442458CS
156-5.83-29.729729729719.6124.134.8520574514.05295191CS
260-23.5-63.036480686737.2839.974.8519931018.55419542CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.3999
(0.00%)
2.07k
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.2684
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.78
(0.00%)
5.28k
AACIArmada Acquisition Corporation I
$ 11.5001
(0.00%)
1,000
AACGATA Creativity Global
$ 0.87
(0.00%)
841
AAGRAfrican Agriculture Holdings Inc
$ 0.3999
(0.00%)
2.07k
AADRAdvisorShares Dorsey Wright ADR ETF
$ 60.2684
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.78
(0.00%)
5.28k
AACIArmada Acquisition Corporation I
$ 11.5001
(0.00%)
1,000
AACGATA Creativity Global
$ 0.87
(0.00%)
841
SPCBSuperCom Ltd
$ 0.2236
(0.00%)
20.7M
AIREreAlpha Tech Corporation
$ 1.16
(0.00%)
17.65M
SGBXSafe and Green Holdings Corporation
$ 0.1441
(0.00%)
13.65M
SQQQProShares UltraPro Short QQQ
$ 11.81
(0.00%)
11.74M
ILAGIntelligent Living Application Group Inc
$ 0.54
(0.00%)
10.67M

Discussion

View Full Feed
ANTI-BAGHOLDER ANTI-BAGHOLDER 1 minute ago
Literally can’t stay on topic. This has nothing to do with any other ticker than MDCE.

You are the one pumping “monster news” weekly for years.

It’s fair to call you out on something that is so ridiculous.

Living in the middle of PA don’t make you ric
MDCE
Tiger Money Tiger Money 1 minute ago
Hunterj20. Just curious with your 10-15 gain like I have already, do you sell and get back in? Or hold and sell at 2.50? Then get back in?
AGBA
Penny Trades Penny Trades 1 minute ago
What are you a jilted ex lover of this guy or what?

It’s been years now and you’re still bashing this company. Lol wow

I feel like I’m watching the real life, baby reindeer movie, slow your roll Martha.
TREP
dranesthesia1 dranesthesia1 1 minute ago
Interesting all your remarks are about gender and chauvinistic. I guess thats why you live alone
SPZI
ThekidOG ThekidOG 2 minutes ago
And that'll be the last post I read from you shady dragon lady , goodbye and good luck to you ... Blocked
NWGC
Bodhi_Trades Bodhi_Trades 2 minutes ago
$NEM Up on earnings today
NEM
s404n1tn0cc s404n1tn0cc 2 minutes ago
Yahh sure try rebuying. Fraud at its best>
LEHNQ
bambam56 bambam56 2 minutes ago
Does this company even have any ca$h ?
Multi million dollars needed for projects, giant hydrogen companies currently developing infrastructures and and seeking government funds to assist. We're to believe puny RONN is a big part of this? Would not be a trip stock if it were.
Hydrogen
H
tdbowieknife tdbowieknife 2 minutes ago
It could be it didn't pass inspection at the New York port. No bugs, seeds, and such are allowed. It could be in quarantine.


.

Buyer Beware
Pump and Dump
http://images.investorshub.advfn.com/images/uploads/2013/12/13/fowqcCaveat_Emptor_5.JPG
IFUS
RMS555 RMS555 2 minutes ago
Yesterdays Short Volume for KEGS: 45,183,976 shares - 84.74 % https://fintel.io/ss/us/kegs

"just show them the facts and watch them spin and squirm" (29YEARINVESTOR)

Lets Go KEGS! More Good News!

https://www.otcmarkets.com/stock/KEGS/news
KEGS
georgie18 georgie18 2 minutes ago
NSAV...0047s clearing here off the .0039 Alert...🥳

georgie18

Member Level
Re: None

Thursday, April 25, 2024 7:59:28 AM

Post#
380135
of 380145
NSAV...0039... https://schrts.co/hUBgtRBY ...🥳...Ch
NSAV
Jp_SHMP Jp_SHMP 2 minutes ago
0.0142 double bottom.. looking good
IGPK
valleybenedetto valleybenedetto 2 minutes ago
Yes GTSM just went 0276 to hide the bid. Criminal. Trading ahead of real orders.
CLNV
ChannelTrader ChannelTrader 2 minutes ago
Ha...I can see the accidents and houses getting hit.
LOL I do not think from what I see that people can handle this invention
Flying Car Makes World’s First Flight With Passenger

https://truthpress.com/news/flying-car-makes-worlds-first-flight-with-passenger/
29YEARINVESTOR 29YEARINVESTOR 2 minutes ago
Drifting lower! I think because the otc update was not delivered on time!
Looks like MM’s will take advantage of it.
IGPK
linkvest linkvest 2 minutes ago
LOL.. I think I remember him. It has been a while ago...
IGPK
nyt nyt 2 minutes ago
Coward? I'm sorry, but not deserving of that much credit...
VPLM
RobotDroid RobotDroid 2 minutes ago
I feel and have been feeling your pain on this stock, thus my lack of faith in management to get anything done on time and even talk to the shareholders. You simply stated what many of us feel, and tomorrow never ever seems to come but keeps getting promised. The lack of transperity, communication,
NWBO
lucky, mydog lucky, mydog 2 minutes ago
lololol;

1) The process of recovering our investment continues...
2) There is no new information to report...
3) The project is still awaiting a deal ...
4) No updates are available at this time...
5) I don’t have visibility...
SIRC
DaBenDan DaBenDan 2 minutes ago
Plenty of scams have access to the CEO, heck the CEO usually has an account here to feed info. The guy wants to create an exchange and can't get past FINRA.
RGLG
wingnutt01 wingnutt01 2 minutes ago
Our Commander should be honored to be Your Captain.

https://www.youtube.com/watch?v=mA-CBXuTaeo
FNMA
Twilson Twilson 3 minutes ago
out small gain
Tiger Money Tiger Money 3 minutes ago
I’m pretty sure the valentine managers thought they were buying a good thing at the price they did when they did. They are hedge funds who got it wrong like us. Well, I speak for myself when I say that, as I thought with this technology we would already be on the big boards
SONX
ProfitScout ProfitScout 3 minutes ago
$RENB News: RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

LOS ANGELES and AMSTERDAM, April 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a trailblazer in AI-driven early cancer diagnostics and therapeutics, an
RENB

Your Recent History

NASDAQ
URGN
UroGen Pharma
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved